Oksana Temirbekova leads YamaYami as CEO. The Device for local transdermal drug delivery and gene therapy developed by her became one of the best inventions according to IFIA (International Federation of Inventors’Associations), the Korean Intellectual Property Office (KIPO) and the Korea Women Inventors Association (KWIA) in 2024.
Under her leadership, the transdermal technology was included in the list of the TOP-10 most promising technologies in the world according to Sephora/LVMH.
CEO, CO-founder YamaYami
Oksana Temirbekova
FACTS
The best innovative female manager among the BRICs
In 2021 she became the best innovative female manager among the BRICs countries according to the assessment of the international company Deloitte.
MISSION
OUR
MISSION
Our mission is to improve the quality of human life through increasing the effectiveness of drugs.
Every day we work on the efficiency of drug delivery and increasing their effectiveness.
When we first checked out our new headphones, we noticed the box said 'improved bass by cool. We had to wonder, is this marketing jargon, or the real thing? But it only took a moment to realize that bass was not kidding.
More products
CONTACT
CONTACT
Gold award IFIA, KIPO, KWIA
2020-03-22 15:00
Unilever testing product
Successfully passed trials at Unilever and started preparing for FDA and GPM.